Amphetamines only work when 'well lubricated'

June 26, 2013, Medical University of Vienna
Amphetamines only work when 'well lubricated'

The misuse of amphetamines is increasing steadily. Ahead of the "International Day against Drug Abuse" (26th June 2013) MedUni Vienna researchers are presenting a study which unlocks a significant mechanism involved in their action. This could result in treatment options for those dependent on amphetamines.

In their study Harald Sitte and Stefan Böhm from the Centre for Physiology and Pharmacology at the MedUni Vienna investigated the effects of amphetamines on the . The results of this basic medical research are very specific: according to these, the effect amphetamines have only unfolds when the cell membranes "lubricate" the serotonin transporters well with the PIP2.

The is a medically significant membrane protein as it is the target of various medications (e.g. antidepressants), but also of various substances that are abused – such as cocaine and amphetamines. The latter substances were therefore also the focus of this study.

The head of the study, Harald Sitte, comments: "Amphetamines are an important group of substances as their use is often played down, and they are promoted as happy pills and cognitive enhancers. A further danger is that new amphetamine-like substances are continually coming onto the market. So-called "" are included as one of these research chemicals for example. We want to understand what risks are connected with these substances and how these substances work in the body."

An important step for the treatment of amphetamine dependence

As well as the discovery that the membrane, in which the serotonin transporters are embedded, exerts a significant influence on the action of amphetamines, the researchers around Sitte were able, in collaboration with the research group around Gerhard Ecker (the University of Vienna), to also identify the site where PIP2 binds to the serotonin transporter.

Sitte goes on to explain the major, practical relevance this discovery has: "The significance of the membrane lipids for the effects of as has been now demonstrated can bring us an important step closer towards the treatment of dependencies on these substances."

"Transmembrane Transporters in Health and Disease" Special Research Department

The study has just been published in the renowned Proceedings of the National Academy for Sciences of the United States of America (PNAS). The article is titled "Amphetamine actions at the serotonin transporter rely on the availability of phosphatidylinositol-4,5-bisphosphate."

Explore further: Compound enhances SSRI antidepressant's effects in mice

More information: www.pnas.org/content/early/201 … /1220552110.abstract

Related Stories

Compound enhances SSRI antidepressant's effects in mice

June 21, 2013
A synthetic compound is able to turn off "secondary" vacuum cleaners in the brain that take up serotonin, resulting in the "happy" chemical being more plentiful, scientists from the School of Medicine at The University of ...

'Traffic' in our cells works both for and against us

May 1, 2013
A mechanism that permits essential substances to enter our cells while at the same time removing from them harmful components also has a "down side." This negative aspect prevents vital drugs, such as anti-cancer drugs, from ...

Legal high Benzo Fury may be dangerous due to stimulant and hallucinogenic effects

April 9, 2013
The 'legal high' known as Benzo Fury may have stimulant as well as hallucinogenic effects according to new research presented at the British Neuroscience Association Festival of Neuroscience today (Tuesday 9 April 2013).

Synthetic drug use rapidly rising in Europe, report finds

May 28, 2013
New synthetic psychoactive substances are making their way into Europe where the Internet is becoming a big challenge in the fight against illicit drugs, the continent's drug agency warned Tuesday.

Short-term use of amphetamines can improve ADHD symptoms in adults

July 27, 2011
Giving amphetamines to adults with Attention Deficit Hyperactivity Disorder (ADHD) can help them control their symptoms, but the side effects mean that some people do not manage to take them for very long. These conclusions ...

Recommended for you

Researchers devise decoy molecule to block pain where it starts

January 16, 2018
For anyone who has accidentally injured themselves, Dr. Zachary Campbell not only sympathizes, he's developing new ways to blunt pain.

Scientists unleash power of genetic data to identify disease risk

January 16, 2018
Massive banks of genetic information are being harnessed to shed new light on modifiable health risks that underlie common diseases.

Blood-vessel-on-a-chip provides insight into new anti-inflammatory drug candidate

January 15, 2018
One of the most important and fraught processes in the human body is inflammation. Inflammatory responses to injury or disease are crucial for recruiting the immune system to help the body heal, but inflammation can also ...

Molecule produced by fat cells reduces obesity and diabetes in mice

January 15, 2018
UC San Francisco researchers have discovered a new biological pathway in fat cells that could explain why some people with obesity are at high risk for metabolic diseases such as type 2 diabetes. The new findings—demonstrated ...

Obese fat becomes inflamed and scarred, which may make weight loss harder

January 12, 2018
The fat of obese people becomes distressed, scarred and inflamed, which can make weight loss more difficult, research at the University of Exeter has found.

Optimized human peptide found to be an effective antibacterial agent

January 11, 2018
A team of researchers in the Netherlands has developed an effective antibacterial ointment based on an optimized human peptide. In their paper published in the journal Science Translational Medicine, the group describes developing ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.